Light Chain Deposition Disease — Trials

Light Chain Deposition Disease — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01078454	Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis	completed	Phase 3	11	National Cancer Institute (NCI)NIH	1	Feb 1, 2022	clinicaltrials

Data updated 22 days agoSource updated Feb 1, 2022source: clinicaltrials